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body and fundus. Repeated UGE showed no mucosal de-
fect. Radial endoscopic ultrasound (EUS) was performed, 
indicating a submucosal vessel arising in the greater cur-
vature of the proximal gastric body which identified a 
Dieulafoy’s lesion as the possible source of bleeding. Con-
sidering clinical stability, EUS-guided therapy with linear 
scope was planned for the next morning when the scope 
was available, but rebleeding occurred. UGE was per-
formed with a therapeutic scope, as the site of bleeding 
was already identified and active bleeding was expected. 
Thus, the advantages of a dual channel scope, which is 
more easily maneuvered, would outweigh the advantages 
of using the echoendoscope, which has the main benefit 
when the Dieulafoy’s lesion cannot be identified on UGE 
because it is no longer bleeding. UGE revealed an adher-
ent clot in the suspected Dieulafoy’s lesion location previ-
ously described on EUS. After the first clip deployment, 
massive bleeding occurred. Hemostasis was achieved af-
ter adrenalin and polidocanol injection and clipping. EUS 
was performed to confirm vessel obliteration but still 
identified a large caliber (2.5 mm) feeding vessel arising 
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 A 28-year-old man without any remarkable past med-
ical history presented with hematemesis and hemody-
namic instability. There was no significant past medical 
history. He denied any medication intake, namely non-
steroidal anti-inflammatory drugs, alcohol abuse, or 
smoking habits. Upper gastrointestinal endoscopy (UGE) 
revealed fresh blood and a giant clot covering the gastric 
 Received: July 22, 2016 
 Accepted after revision: September 16, 2016 
 Published online: November 22, 2016 
 Dr. Rita Barosa  
 Department of Gastroenterology, Hospital Garcia de Orta  
 Avenida Torrado da Silva  
 PT–2801-951 Almada (Portugal) 
 E-Mail a.rita.b   @   gmail.com  
 © 2016 Sociedade Portuguesa de Gastrenterologia
Published by S. Karger AG, Basel
 
 www.karger.com/pjg Th is article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-




 GE Port J Gastroenterol 2017;24:95–97 
DOI: 10.1159/000450902
96
from the splenic artery penetrating the gastric muscularis 
propria ( Fig. 1 ). Selective splenic artery angiogram as de-
termined by EUS was performed, revealing a short gastric 
artery ectasia and hypervascularization ( Fig. 2 , large ar-
row) ending in the previously endoscopically placed clips 
( Fig. 2 , small arrow). Superselective transcatheter arterial 
embolization (TAE) was performed, and the patient pre-
sented no further episodes of gastrointestinal bleeding at 
the 1-year follow-up.
 Dieulafoy’s lesion is a relatively rare cause of upper 
gastrointestinal bleeding which may be difficult to detect 
on endoscopy in the case of nonactive bleeding  [1] . EUS 
may be used to identify a nonactively bleeding Dieula-
foy’s lesion, to perform EUS-guided therapy, and to mon-
itor therapy effectiveness  [1, 2] . In fact, it is our practice 
to perform EUS after inconclusive UGE in a severe upper 
gastrointestinal bleeding setting, clinically suggestive of 
Dieulafoy’s lesion origin, and we also systematically per-
form EUS after endoscopic therapy to confirm effective 
vessel obliteration  [3] . When refractory to endoscopic 
treatment, surgery and TAE should be considered  [1] . 
Marking the lesion with a metallic clip has accurately 
guided the endovascular intervention in cases of nonac-
tive bleeding ulcer and may be equally useful in the treat-
ment of Dieulafoy’s lesions  [4] . With this case, we empha-
size the role of EUS as a roadmap for other interventions, 
such as selective TAE.
 Fig. 1. Large caliber (2.5 mm) feeding ves-
sel arising from the splenic artery penetrat-
ing the gastric muscularis propria. 
 Fig. 2. Selective splenic artery angiogram revealing a short gastric 
artery ectasia and hypervascularization (large arrow) ending in the 
previously endoscopically placed clips (small arrow). 
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